Ketek Superiority Trials May Hold Key To Sales After Safety Relabeling
Executive Summary
Sanofi-Aventis recently conducted superiority trials for its antibiotic Ketek, and the results could determine whether the drug bounces back from an FDA decision to withdraw two indications from the drug's label
You may also be interested in...
Antibiotic Trial Standards To Be Revised By FDA Under Congressional Mandate
Manufacturers of antibiotics need to get involved as FDA writes clinical trial guidance for antibiotic drugs, according to Bruce Burlington, an independent consultant and former Wyeth VP
Antibiotic Trial Standards To Be Revised By FDA Under Congressional Mandate
Manufacturers of antibiotics need to get involved as FDA writes clinical trial guidance for antibiotic drugs, according to Bruce Burlington, an independent consultant and former Wyeth VP
PDUFA Public Forum Previews Hill Debate; Safety, Critical Path Emphasized
With the Prescription Drug User Fee Act moving towards reauthorization, a public forum on Feb. 16 hinted at how that debate may play out on Capitol Hill. At the meeting sponsored by FDA, outside groups voiced concerns about the agency's proposal for the PDUFA program and made their case for how FDA should organize and spend requested funding